Companies / Japan
Eiasi Expands In US
May 2007 | Industry NewsNorth America has became Japanese drugmaker Eisai 's largest market last year with sales reaching JPY303.4bn (US$2.5bn), around 45% of total turnover. The strong performance was driven by surging demand for leading products such as Alzheimer's drug Aricept (donepezil) and ulcer treatment Aciphex (rabeprazole).
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
